Muramyl tripeptide in chemotherapy improves overall osteosarcoma survival
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology GroupJ Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Dr. Paul A. Meyers discusses the addition of muramyl tripeptide to chemotherapy in the treatment of Osteosarcoma.
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE